Loading...

Neovasc Inc.

NVCN•NASDAQ
Healthcare
Medical - Devices
$30.03
$0.00(0.00%)

Neovasc Inc. (NVCN) Stock Overview

Explore Neovasc Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.1/100

Key Financials

Market Cap82.9M
P/E Ratio-1.99
EPS (TTM)$-15.07
ROE-1.21%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.35

NVCN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Neovasc Inc. (NVCN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.99 and a market capitalization of 82.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;